| Name: | Montelukast EP Impurity H |
| Catalogue No. | VE006304 |
| CAS No. | 851755-56-1 |
| Molecular Formula | C34H32ClNO4S |
| Molecular Weight | 586.14 |
| Status | In-stock |
| IUPAC Name | :2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(methoxycarbonyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid |
| Synonyms | Montelukast Methoxycarbonyl Analog |
| Description | Montelukast EP Impurity H (CAS No: 851755-56-1) or Montelukast Methoxycarbonyl Analog is an impurity present in montelukast which is a specific cysteinyl leukotriene receptor antagonist, belonging to the quinoline series and therapeutic agent extensively used for the treatment of bronchial asthma and allergic rhinitis. |
| References | Barnabas, K. Samuel, et al. “A Novel Stability-Indicating Method for Determination of Related Substances of Montelukast Sodium in a Pharmaceutical Dosage Form Using RP-HPLC.” Chromatographia, vol. 84, no. 7, June 2021, pp. 645–62, https://doi.org/10.1007/s10337-021-04045-8. Pandey, Lawanya, et al. A REVIEW on TOXICOLOGICAL STUDY of MONTELUKAST. www.ijramr.com/sites/default/files/issues-pdf/3731.pdf. |
